The Effect of a Novel Preclinical Agent, SpiD3, on Drug-resistant Chronic Lymphocytic Leukemia
Ontology highlight
ABSTRACT: The Effect of a Novel Preclinical Agent, SpiD3, on Drug-resistant Chronic Lymphocytic Leukemia
PROVIDER: PRJNA1109754 | ENA |
REPOSITORIES: ENA
ACCESS DATA